计算溶液所需的质量、体积或浓度。
Glembatumumab (anti-GPNMB) (Ab175888) - ELISA
Immobilized huGPNMB-his at 2.0 μg/mL can bind Glembatumumab (anti-GPNMB) (Ab175888) with the EC₅₀ of 40.9 ng/mL.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| Ab175888-100μg |
100μg |
现货 ![]() |
| |
| Ab175888-1mg |
1mg |
现货 ![]() |
| |
| Ab175888-5mg |
5mg |
现货 ![]() |
| |
| Ab175888-10mg |
10mg |
期货 ![]() |
|
| 产品名称 | Glembatumumab (anti-GPNMB), 跨膜糖蛋白的结合剂 NMB 结合剂 |
|---|---|
| 别名 | 格列巴单抗(抗 GPNMB) |
| 英文别名 | Hematopoietic growth factor inducible neurokinin-1 type |
| 规格或纯度 | 无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA |
| 宿主种属 | 人(Human) |
| 特异性 | GPNMB |
| 种属反应性 | 人(Human) |
| 偶联 | Unconjugated |
| 作用类型 | 结合剂 |
| 作用机制 | 跨膜糖蛋白的结合剂 NMB 结合剂 |
| 克隆类型 | 重组抗体 |
|---|---|
| Format | Whole IgG |
| 亚型 | Human IgG2 |
| 轻链亚型 | kappa |
| SDS-PAGE | 145.56 kDa |
| 纯化方法 | Protein A purified |
| 纯度 | >95% |
| 物理外观 | Liquid |
| 储存缓冲液 | Supplied as a 0.22 μm filtered solution in 100mM Pro-Ac, 20mM Arg, pH 5.0 |
| 防腐剂 | No |
| 浓度 | 见COA |
| 储存温度 | -80℃储存,避免反复冻融 |
| 运输条件 | 超低温冰袋运输 |
| 稳定性与储存 | 在 -80℃ 下保存 24 个月。收货后建议分装。避免冷冻/解冻循环。 |
| CAS编号和信息 | 1020264-78-1 |
| 分子类型 | 抗体 |
Glembatumumab (anti-GPNMB) (Ab175888) - ELISA
Immobilized huGPNMB-his at 2.0 μg/mL can bind Glembatumumab (anti-GPNMB) (Ab175888) with the EC₅₀ of 40.9 ng/mL.
Glembatumumab (anti-GPNMB) (Ab175888) - SEC
The purity of Glembatumumab (anti-GPNMB) (Ab175888) is more than 95% verified by HPLC.
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!
| 批号(Lot Number) | 证书类型 | 日期 | 货号 |
|---|---|---|---|
| 分析证书 | 24-11-21 | Ab175888 | |
| 分析证书 | 24-11-21 | Ab175888 | |
| 分析证书 | 24-11-21 | Ab175888 | |
| 分析证书 | 24-04-08 | Ab175888 | |
| 分析证书 | 24-04-08 | Ab175888 | |
| 分析证书 | 24-04-08 | Ab175888 |
| 1. Rose AA, Grosset AA, Dong Z, Russo C, Macdonald PA, Bertos NR, St-Pierre Y, Simantov R, Hallett M, Park M et al.. (2010) Glycoprotein nonmetastatic B is an independent prognostic indicator of recurrence and a novel therapeutic target in breast cancer.. Clin Cancer Res, 16 (7): (2147-56). [PMID:20215530] |
| 2. Tse KF, Jeffers M, Pollack VA, McCabe DA, Shadish ML, Khramtsov NV, Hackett CS, Shenoy SG, Kuang B, Boldog FL et al.. (2006) CR011, a fully human monoclonal antibody-auristatin E conjugate, for the treatment of melanoma.. Clin Cancer Res, 12 (4): (1373-82). [PMID:16489096] |
| 3. Kuan CT, Wakiya K, Dowell JM, Herndon 2nd JE, Reardon DA, Graner MW, Riggins GJ, Wikstrand CJ, Bigner DD. (2006) Glycoprotein nonmetastatic melanoma protein B, a potential molecular therapeutic target in patients with glioblastoma multiforme.. Clin Cancer Res, 12 (7 Pt 1): (1970-82). [PMID:16609006] |
| 4. Weterman, M A MA and 6 more authors.. (1995) nmb, a novel gene, is expressed in low-metastatic human melanoma cell lines and xenografts.. International journal of cancer, (3): [PMID:7814155] |
| 5. Bandari, Persis S PS and 9 more authors.. (2003) Hematopoietic growth factor inducible neurokinin-1 type: a transmembrane protein that is similar to neurokinin 1 interacts with substance P.. Regulatory peptides, (28): [PMID:12609765] |
| 6. Basrur, Venkatesha V and 12 more authors.. Proteomic analysis of early melanosomes: identification of novel melanosomal proteins.. Journal of proteome research, [PMID:12643545] |
| 7. Chi, An A and 16 more authors.. (2006) Proteomic and bioinformatic characterization of the biogenesis and function of melanosomes.. Journal of proteome research, [PMID:17081065] |
| 8. Yang, Chi-Fan CF and 7 more authors.. (2018) Loss of GPNMB Causes Autosomal-Recessive Amyloidosis Cutis Dyschromica in Humans.. American journal of human genetics, (1): [PMID:29336782] |